Since 1987, this dedicated community has stood shoulder to shoulder with the SRF, helping to drive research toward a cure for scleroderma. Because of your generosity and commitment, 2024 was...
Read More
Navigating clinical trials can feel overwhelming, but finding accurate, reliable information shouldn’t be. Our new clinical trial page is designed to empower you with resources and support to make informed...
Read More
Last week, the CONQUEST team had the incredible opportunity to visit Japan! 🇯🇵 CONQUEST is a global platform clinical trial created by the Scleroderma Research Foundation with input from partner...
Read More
The goal of all clinical trials is to be as inclusive as possible. However, it is necessary to develop specific inclusion and exclusion criteria. The reason for this is to...
Read More
This year, the SRF was proud to be represented by our Chief Medical Officer, Dr. Gregory Gordon, at the EULAR Congress 2024 in Vienna, Austria. Held from June 12-15, the…
San Francisco, CA (June 25, 2024)—CONQUEST, a highly innovative platform clinical trial conceived of and led by the Scleroderma Research Foundation (SRF) and designed to rapidly advance promising treatments for...
Read More
We are honored to announce that CONQUER has enrolled its 1,000th participant! 🎉 In 2018, the SRF launched the CONQUER Registry (an acronym for COllaborative National QUality and Efficacy Registry)—a first-of-its-kind nationwide…
Register now for "Collaborating for a Cure," the SRF Patient Forum, on June 3rd! 📋 You're invited to a FREE virtual forum for people living with #scleroderma and those who care...
Read More
Here at the Scleroderma Research Foundation, research is at the center of all we do to find a cure—and that's only possible because of the dedicated support of our community....
Read More
Research is at the center of all we do here at the SRF to find a cure for scleroderma. This is why, in 2018, we launched CONQUER (COllaborative, National QUality...
Read More
